BRONKOSOL Drug Patent Profile
✉ Email this page to a colleague
When do Bronkosol patents expire, and when can generic versions of Bronkosol launch?
Bronkosol is a drug marketed by Sanofi Aventis Us and is included in one NDA.
The generic ingredient in BRONKOSOL is isoetharine hydrochloride. There are four drug master file entries for this compound. Additional details are available on the isoetharine hydrochloride profile page.
Summary for BRONKOSOL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 49 |
Formulation / Manufacturing: | see details |
DailyMed Link: | BRONKOSOL at DailyMed |
US Patents and Regulatory Information for BRONKOSOL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi Aventis Us | BRONKOSOL | isoetharine hydrochloride | SOLUTION;INHALATION | 012339-009 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sanofi Aventis Us | BRONKOSOL | isoetharine hydrochloride | SOLUTION;INHALATION | 012339-008 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |